EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Across the Ejection Fraction Spectrum: A Multistate Real-World Cohort

Michel Chedid El Helou, Karim Hoyek, Harsh Patolia, Michael Hill, Ziad Zalaquett, Hunter Block-Beach, Ashish Sarraju, Amanda R Vest, Nancy M Albert, Randall C Starling, Trejeeve Martyn

Journal of Cardiac Failure · 2026-10

DOI: 10.1016/j.cardfail.2026.09.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026-10. Verfasst von Michel Chedid El Helou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; George M. and Linda Kaufman Cent…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

comparative effectivenessejection fractionheart failuresacubitril/valsartan

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; George M. and Linda Kaufman Center for Heart Failure and Recovery, Cleveland Clinic, Cleveland, Ohio,…
  • Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; C5 Research, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • George M. and Linda Kaufman Center for Heart Failure and Recovery, Cleveland Clinic, Cleveland, Ohio, USA.

Zitieren

APA

Helou, M. C. E., Hoyek, K., Patolia, H., Hill, M., Zalaquett, Z., Block-Beach, H., Sarraju, A., Vest, A. R., Albert, N. M., Starling, R. C., & Martyn, T. (2026). Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Across the Ejection Fraction Spectrum: A Multistate Real-World Cohort. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2026.09.021

Vancouver

Helou MCE, Hoyek K, Patolia H, Hill M, Zalaquett Z, Block-Beach H, et al. Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Across the Ejection Fraction Spectrum: A Multistate Real-World Cohort. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2026.09.021

BibTeX
@article{Helou2026,
  author = {Helou, Michel Chedid El and Hoyek, Karim and Patolia, Harsh and Hill, Michael and Zalaquett, Ziad and Block-Beach, Hunter and Sarraju, Ashish and Vest, Amanda R and Albert, Nancy M and Starling, Randall C and Martyn, Trejeeve},
  title = {Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Across the Ejection Fraction Spectrum: A Multistate Real-World Cohort},
  journal = {Journal of Cardiac Failure},
  year = {2026},
  doi = {10.1016/j.cardfail.2026.09.021}
}
Kostenlos starten →